tiprankstipranks
Advertisement
Advertisement

Concentra Posts Strong Q4 Results and Raises 2026 Outlook

Story Highlights
  • Concentra’s preliminary 2025 results beat prior guidance, with double-digit revenue growth, stronger profitability, and rapid expansion of clinics and patient visits.
  • Looking to 2026, Concentra forecasts further revenue and EBITDA growth, stronger free cash flow, and lower leverage while enhancing investor outreach with a new Investor Book.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Concentra Posts Strong Q4 Results and Raises 2026 Outlook

Claim 55% Off TipRanks

Concentra Group Holdings Parent, Inc. ( (CON) ) has issued an announcement.

On January 28, 2026, Concentra announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, showing that it exceeded its prior full-year guidance and extended its lead in the U.S. occupational health market. Fourth-quarter 2025 revenue rose 15.9% year over year to $539.1 million, net income climbed 58.7% to $36.2 million, and adjusted EBITDA increased 22.9% to $95.3 million, driven by a 9% rise in daily patient visits, higher revenue per visit, significant expansion to 628 occupational health centers and 411 onsite clinics, and continued share repurchases. For full-year 2025, Concentra expects revenue of $2.16 billion, up 13.9% from 2024, adjusted EBITDA of $431.9 million, higher revenue per visit, free cash flow of $197.8 million, and a net leverage ratio of about 3.4x, underpinned by increased capital expenditures to support rapid network growth. The company also issued 2026 guidance calling for further gains, with revenue projected between $2.25 billion and $2.35 billion, adjusted EBITDA of $450 million to $470 million, free cash flow of $200 million to $225 million, and lower leverage of 3.0x or below, and scheduled the release of full 2025 results for February 26, 2026, followed by an earnings call on February 27, 2026; alongside the numbers, Concentra published its first Investor Book to deepen market understanding of its business model and growth strategy, signaling confidence in sustained expansion and an effort to reinforce its positioning with investors and other stakeholders.

The most recent analyst rating on (CON) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Concentra Group Holdings Parent, Inc. stock, see the CON Stock Forecast page.

Spark’s Take on CON Stock

According to Spark, TipRanks’ AI Analyst, CON is a Neutral.

The score is driven primarily by solid-but-mixed fundamentals: improving leverage and decent revenue growth are offset by declining profitability margins and negative free-cash-flow growth. The earnings call adds support through raised guidance and strong volume/EBITDA growth, while technicals remain neutral-to-weak and valuation is reasonable rather than compelling.

To see Spark’s full report on CON stock, click here.

More about Concentra Group Holdings Parent, Inc.

Concentra Group Holdings Parent, Inc., listed on the NYSE under the ticker CON, is the largest provider of occupational health services in the United States by number of locations. The company delivers occupational and consumer health services and other direct-to-employer care through 628 occupational health centers, 411 onsite health clinics at employer worksites, and its Concentra Telemed platform across 47 states, serving roughly 53,000 patients per day as of December 31, 2025, with a mission focused on improving the health of America’s workforce.

Average Trading Volume: 959,484

Technical Sentiment Signal: Buy

Current Market Cap: $2.84B

For an in-depth examination of CON stock, go to TipRanks’ Overview page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1